RxDoctor Payments Data

Ronan Allencherril

Houston, TXNPI 1306475165

Payments from drug & device makers

$6,108in general payments, 2019–2025

Across 124 payments — averaging $49.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sanofi$925
  • Johnson & Johnson$565
  • Regeneron Healthcare Solutions, Inc.$425
  • Takeda Pharmaceuticals U.S.A., Inc.$383
  • Janssen Scientific Affairs, LLC$378
  • plus $2K from 12 others

What the payments were for

  • Food & beverage$6,108100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lubiprostone13$2,544
Promethazine Hcl15$319
Pantoprazole Sodium14$181

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →